Literature DB >> 16299305

Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping.

Job E Lopez1, William F Siems, Guy H Palmer, Kelly A Brayton, Travis C McGuire, Junzo Norimine, Wendy C Brown.   

Abstract

Immunization with purified Anaplasma marginale outer membranes induces complete protection against infection that is associated with CD4+ T-lymphocyte-mediated gamma interferon secretion and immunoglobulin G2 (IgG2) antibody titers. However, knowledge of the composition of the outer membrane immunogen is limited. Recent sequencing and annotation of the A. marginale genome predicts at least 62 outer membrane proteins (OMP), enabling a proteomic and genomic approach for identification of novel OMP by use of IgG serum antibody from outer membrane vaccinates. Outer membrane proteins were separated by two-dimensional electrophoresis, and proteins recognized by total IgG and IgG2 in immune sera of outer membrane-vaccinated cattle were detected by immunoblotting. Immunoreactive protein spots were excised and subjected to liquid chromatography-tandem mass spectrometry. A database search of the A. marginale genome identified 24 antigenic proteins that were predicted to be outer membrane, inner membrane, or membrane-associated proteins. These included the previously characterized surface-exposed outer membrane proteins MSP2, operon associated gene 2 (OpAG2), MSP3, and MSP5 as well as recently identified appendage-associated proteins. Among the 21 newly described antigenic proteins, 14 are annotated in the A. marginale genome and include type IV secretion system proteins, elongation factor Tu, and members of the MSP2 superfamily. The identification of these novel antigenic proteins markedly expands current understanding of the composition of the protective immunogen and provides new candidates for vaccine development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299305      PMCID: PMC1307060          DOI: 10.1128/IAI.73.12.8109-8118.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

1.  Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection.

Authors:  G M Winslow; E Yager; K Shilo; E Volk; A Reilly; F K Chu
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 2.  Bacterial type IV secretion: conjugation systems adapted to deliver effector molecules to host cells.

Authors:  P J Christie; J P Vogel
Journal:  Trends Microbiol       Date:  2000-08       Impact factor: 17.079

3.  Outer membrane protein-specific monoclonal antibodies protect SCID mice from fatal infection by the obligate intracellular bacterial pathogen Ehrlichia chaffeensis.

Authors:  J S Li; E Yager; M Reilly; C Freeman; G R Reddy; A A Reilly; F K Chu; G M Winslow
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

4.  Emergence of Anaplasma marginale antigenic variants during persistent rickettsemia.

Authors:  D M French; W C Brown; G H Palmer
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains.

Authors:  W C Brown; G H Palmer; H A Lewin; T C McGuire
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses.

Authors:  W C Brown; T C McGuire; D Zhu; H A Lewin; J Sosnow; G H Palmer
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

7.  Identification of Brucella suis genes affecting intracellular survival in an in vitro human macrophage infection model by signature-tagged transposon mutagenesis.

Authors:  V Foulongne; G Bourg; C Cazevieille; S Michaux-Charachon; D O'Callaghan
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis.

Authors:  M E Martin; K Caspersen; J S Dumler
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

9.  Antigenic variation of Anaplasma marginale by expression of MSP2 mosaics.

Authors:  A F Barbet; A Lundgren; J Yi; F R Rurangirwa; G H Palmer
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

10.  Antibodies highly effective in SCID mice during infection by the intracellular bacterium Ehrlichia chaffeensis are of picomolar affinity and exhibit preferential epitope and isotype utilization.

Authors:  Julia Shu-Yi Li; Frederick Chu; Andrew Reilly; Gary M Winslow
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

View more
  51 in total

1.  Association of pathogen strain-specific gene transcription and transmission efficiency phenotype of Anaplasma marginale.

Authors:  Joseph T Agnes; David Herndon; Massaro W Ueti; Solomon S Ramabu; Marc Evans; Kelly A Brayton; Guy H Palmer
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

2.  Immunoproteomic analysis to identify Shiga toxin-producing Escherichia coli outer membrane proteins expressed during human infection.

Authors:  David Montero; Paz Orellana; Daniela Gutiérrez; Daniela Araya; Juan Carlos Salazar; Valeria Prado; Angel Oñate; Felipe Del Canto; Roberto Vidal
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

3.  Identification of Anaplasma marginale outer membrane protein antigens conserved between A. marginale sensu stricto strains and the live A. marginale subsp. centrale vaccine.

Authors:  Joseph T Agnes; Kelly A Brayton; Megan LaFollett; Junzo Norimine; Wendy C Brown; Guy H Palmer
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

4.  Genome-wide screening and identification of antigens for rickettsial vaccine development.

Authors:  Guy H Palmer; Wendy C Brown; Susan M Noh; Kelly A Brayton
Journal:  FEMS Immunol Med Microbiol       Date:  2012-02

5.  Analysis of the Anaplasma marginale major surface protein 1 complex protein composition by tandem mass spectrometry.

Authors:  Henriette Macmillan; Kelly A Brayton; Guy H Palmer; Travis C McGuire; Gerhard Munske; William F Siems; Wendy C Brown
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

6.  TLR4-dependent activation of inflammatory cytokine response in macrophages by Francisella elongation factor Tu.

Authors:  Jyotika Sharma; Bibhuti B Mishra; Qun Li; Judy M Teale
Journal:  Cell Immunol       Date:  2011-03-29       Impact factor: 4.868

7.  Physical linkage of naturally complexed bacterial outer membrane proteins enhances immunogenicity.

Authors:  Henriette Macmillan; Junzo Norimine; Kelly A Brayton; Guy H Palmer; Wendy C Brown
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

8.  Immunoproteomic analysis of the development of natural immunity in subjects colonized by Neisseria meningitidis reveals potential vaccine candidates.

Authors:  Jeannette N Williams; Paul J Skipp; C David O'Connor; Myron Christodoulides; John E Heckels
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

9.  Immunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale.

Authors:  Pablo A Nuñez; Rosalia Moretta; Paula Ruybal; Silvina Wilkowsky; Marisa D Farber
Journal:  Curr Microbiol       Date:  2013-10-15       Impact factor: 2.188

Review 10.  Phylogenomics reveals a diverse Rickettsiales type IV secretion system.

Authors:  Joseph J Gillespie; Kelly A Brayton; Kelly P Williams; Marco A Quevedo Diaz; Wendy C Brown; Abdu F Azad; Bruno W Sobral
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.